person · Reporting owner

Hunter James Randolph Jr

Disclosed activity across 1 company

Tapewire entity: 47400
SEC CIK: 0002071788

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Tonix Pharmaceuticals Holding Corp.TNXP · Entity 6169	Director	May 12, 2026	May 14, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Tonix Pharmaceuticals Holding Corp.

Report date May 12, 2026 · Filed May 14, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $13.28 · Expires 2036-05-12	Direct	22,700	Reported balance After 2026-05-12 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-05-12 · Grant · Acquired 22,700 · Balance 22,700 F1: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

Filing footnotes · ownership attribution and instrument terms

F1: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 12, 2026 Filed May 14, 2026 21:46 UTC	Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169	GrantStock Option · Derivative	22,700	$0.00 Strike: $13.28	$0.00	Disclosure SEC source: 0001999371-26-010751 · hunter-form4_051426.xml · derivative · entry 1 Hunter James Randolph Jr · CIK 0002071788 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,700 Underlying: Common Stock · 22,700 shares Expires 2036-05-12 F1 · price: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders. F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders. Read SEC document
June 12, 2025 Filed Jun 13, 2025 20:42 UTC	Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169	GrantStock Option · Derivative	7,740	$0.00 Strike: $34.54	$0.00	Disclosure SEC source: 0001999371-25-007769 · hunter-form4.xml · derivative · entry 1 Hunter James Randolph Jr · CIK 0002071788 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,740 Underlying: Common Stock · 7,740 shares Expires 2035-06-12 F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended. F1 · derivative.exercise_date: The option vests on the date of the Company's 2026 annual meeting of stockholders. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.